Journal
NATURE CELL BIOLOGY
Volume 12, Issue 4, Pages 380-U189Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/ncb2038
Keywords
-
Categories
Funding
- Dutch Cancer Society
- European Young Investigator (EURYI)
- Centre for Biomedical Genetics (CBG)
- European Research Council (ERC)
- Associazione Italiana per la Ricerca sul Cancro
- Ministero dell'Universita e della Ricerca
- EC [503576, 502963]
Ask authors/readers for more resources
Oncogene-induced senescence is a p53-dependent defence mechanism against uncontrolled proliferation. Consequently, many human tumours harbour p53 mutations and others show a dysfunctional p53 pathway, frequently by unknown mechanisms. Here we identify BRD7 (bromodomain-containing 7) as a protein whose inhibition allows full neoplastic transformation in the presence of wild-type p53. In human breast tumours harbouring wild-type, but not mutant, p53 the BRD7 gene locus was frequently deleted and low BRD7 expression was found in a subgroup of tumours. Functionally, BRD7 is required for efficient p53-mediated transcription of a subset of target genes. BRD7 interacts with p53 and p300 and is recruited to target gene promoters, affecting histone acetylation, p53 acetylation and promoter activity. Thus, BRD7 suppresses tumorigenicity by serving as a p53 cofactor required for the efficient induction of p53-dependent oncogene-induced senescence.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available